219 studies found for:    treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV
Show Display Options
RSS Create an RSS feed from your search for:
treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome;   HIV Infections
Interventions: Drug: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);   Drug: second line ARV therapy (3TC+TDF+LPV/RTV)
2 Unknown  Raltegravir in the Swiss HIV Cohort Study
Condition: HIV Infection
Intervention: Drug: Raltegravir
3 Recruiting Assessment of Group Peer Support to Children With HIV in Vietnam
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Behavioral: Enhanced Treatment Support (ETS)
4 Unknown  Once Daily 3TC, Efavirenz and ddI for HIV Infection
Conditions: HIV Infection;   AIDS
Intervention: Drug: once daily minimum 3-drug regimen of anti-retroviral medications
5 Unknown  The Detection of Drug-Resistant HIV-1 in Taiwan
Condition: HIV Infections
Intervention:
6 Unknown  Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
7 Unknown  A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Conditions: HIV-1;   HIV Infections
Interventions: Other: VircoType HIV-1 genotypic interpretation;   Other: Local Expert Review of HIV Genotypic resistance testing
8 Recruiting Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: ATV;   Drug: DRV;   Drug: Cobicistat;   Drug: BR
9 Unknown  Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
Intervention:
10 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
11 Recruiting Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults
Conditions: HIV-1;   HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: E/C/F/TAF;   Drug: DRV;   Drug: Pre-existing ARV regimen
12 Not yet recruiting Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG;   Drug: LPV/RTV
13 Recruiting Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
Conditions: HIV Infection;   Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
14 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
15 Recruiting Two Part Study to Study Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir (EVG) Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: Elvitegravir;   Drug: RTV-boosted PI
16 Recruiting GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance
Conditions: HIV-1 Infected Patients;   Fold-change Resistance;   Resistance Mutations
Intervention:
17 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
18 Unknown  Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients
Condition: HIV
Intervention: Drug: raltegravir
19 Recruiting Oligonucleotide Ligation Assay (OLA) Resistance Study
Condition: HIV Positive
Intervention: Other: Pre-ART Oligonucleotide Assay (OLA)
20 Recruiting Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults
Conditions: HIV;   HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: TAF;   Drug: Placebo to match TAF;   Drug: E/C/F/TAF;   Drug: Pre-existing ARV regimen;   Drug: ATV

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years